Immunosuppressive Treatment Regimens in Autoimmune Hepatitis: Systematic Reviews and Meta-Analyses Supporting American Association for the Study of Liver Diseases Guidelines
Hepatology
.
2020 Aug;72(2):753-769.
doi: 10.1002/hep.31407.
Authors
John M Vierling
1
,
Nanda Kerkar
2
,
Albert J Czaja
3
,
Cara L Mack
4
,
David Adams
5
,
David N Assis
6
,
Michael P Manns
7
,
Marlyn J Mayo
8
,
Tarek Nayfeh
9
,
Abdul Mounaem M Majzoub
9
,
Muayad A Alzuabi
9
,
Jingyi Ding
9
,
Samir Haffar
9
,
M Hassan Murad
9
,
Mouaz Alsawas
9
Affiliations
1
Departments of Medicine and Surgery, Baylor College of Medicine, Houston, TX, USA.
2
Department of Pediatrics, University of Rochester School of Medicine, Rochester, NY, USA.
3
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN, USA.
4
Department of Pediatrics, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, CO, USA.
5
College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
6
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.
7
Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
8
University of Texas Southwestern Medical Center, Dallas, TX, USA.
9
Mayo Clinic Evidence-Based Practice Research Program, Rochester, MN, USA.
PMID:
32500593
DOI:
10.1002/hep.31407
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Review
MeSH terms
Hepatitis, Autoimmune / drug therapy*
Humans
Immunosuppressive Agents / therapeutic use*
Meta-Analysis as Topic*
Systematic Reviews as Topic*
Substances
Immunosuppressive Agents